Positive News Sentiment NYSE:USNA USANA Health Sciences - USNA Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $62.22 +0.86 (+1.40%) (As of 03/27/2023 11:56 AM ET) Add Compare Share Share Today's Range$61.62▼$62.2250-Day Range$55.44▼$63.4852-Week Range$48.61▼$83.78Volume9,884 shsAverage Volume73,850 shsMarket Capitalization$1.20 billionP/E Ratio17.33Dividend YieldN/APrice Target$52.75 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability USANA Health Sciences MarketRank™ ForecastAnalyst RatingHold1.50 Rating ScoreUpside/Downside14.4% Downside$52.75 Price TargetShort InterestHealthy3.42% of Float Sold ShortDividend StrengthN/ASustainability-1.11Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$1.49 M Sold Last QuarterProj. Earnings Growth15.09%From $2.85 to $3.28 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.05 out of 5 starsMedical Sector579th out of 995 stocksMedicinals & Botanicals Industry4th out of 11 stocks 0.8 Analyst's Opinion Consensus RatingUSANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 1.50, and is based on no buy ratings, 1 hold rating, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $52.75, USANA Health Sciences has a forecasted downside of 14.4% from its current price of $61.62.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.42% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 5.06%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Previous Next 3.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreUSANA Health Sciences has received a 31.40% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Direct selling of nutritional products through representatives", "Direct selling of dietary supplements through representatives", and "Direct selling of skincare products through representatives" products. See details.Environmental SustainabilityThe Environmental Impact score for USANA Health Sciences is -1.11. Previous Next 3.2 News and Social Media Coverage News SentimentUSANA Health Sciences has a news sentiment score of 1.78. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for USANA Health Sciences this week, compared to 2 articles on an average week.Search Interest1 people have searched for USNA on MarketBeat in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,490,529.00 in company stock.Percentage Held by InsidersOnly 0.36% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions52.62% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 15.09% in the coming year, from $2.85 to $3.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 17.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 115.41.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 17.16, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 84.41.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 2.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About USANA Health Sciences (NYSE:USNA) StockUSANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.Read More Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address USNA Stock News HeadlinesMarch 23, 2023 | finance.yahoo.comUtah Governor's Office Recognizes USANA for Its Support of Women in the WorkplaceMarch 6, 2023 | finance.yahoo.comIs USANA Health Sciences, Inc.'s (NYSE:USNA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?March 27, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …March 1, 2023 | nasdaq.comUSNA Makes Bullish Cross Above Critical Moving AverageMarch 1, 2023 | finance.yahoo.comKevin Guest Honors Workers in March Employee Spirit MonthFebruary 23, 2023 | finance.yahoo.comUSANA Executive Director Takes Home Utah AwardFebruary 13, 2023 | finance.yahoo.comUSANA Health Sciences Announces CEO Transition PlanFebruary 13, 2023 | finance.yahoo.comUsana names new CEOMarch 27, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …February 9, 2023 | finance.yahoo.comUSANA Health Sciences, Inc. (NYSE:USNA) Q4 2022 Earnings Call TranscriptFebruary 7, 2023 | msn.comUSANA Health Sciences GAAP EPS of $0.66 beats by $0.31, revenue of $228M beats by $24.2MFebruary 7, 2023 | markets.businessinsider.comUSANA Health Sciences Bottom Line Falls In Q4, but beats estimatesFebruary 7, 2023 | finance.yahoo.comUSANA Health Sciences Reports Fourth Quarter and Fiscal Year 2022 ResultsFebruary 1, 2023 | finance.yahoo.comThe Day the Music Died Celebrates Music, Brings HarmonyJanuary 17, 2023 | finance.yahoo.comHealth and Wellness Company Launches New Affiliate ProgramJanuary 10, 2023 | nasdaq.comUSANA Health Sciences, Inc. Common Stock (USNA)January 5, 2023 | finance.yahoo.comUSANA Health Sciences Provides Preliminary Fiscal Year 2022 Results and Issues Initial Fiscal Year 2023 OutlookJanuary 3, 2023 | finance.yahoo.comKevin Guest Says Start Something for January's Rising Star MonthDecember 22, 2022 | finance.yahoo.comUSANA Kids Eat Delivers Meals and Holiday Spirit to Local Students and FamiliesDecember 21, 2022 | finance.yahoo.comUSANA Health Sciences (NYSE:USNA) investors are sitting on a loss of 48% if they invested a year agoDecember 15, 2022 | finance.yahoo.comUSANA Health Sciences to Participate in the 25th Annual ICR ConferenceDecember 8, 2022 | finance.yahoo.comUSANA Health Sciences Named a Best Company to Work For in UtahDecember 1, 2022 | finance.yahoo.comKevin Guest Says Generate 2023 Personal Life Plan for December's National Business Plan MonthDecember 1, 2022 | finance.yahoo.comUSANA Health Sciences to Participate in the Sidoti Virtual Investor ConferenceNovember 30, 2022 | finance.yahoo.comUSANA Health Sciences (NYSE:USNA) Has Some Difficulty Using Its Capital EffectivelyNovember 28, 2022 | finance.yahoo.comUSANA Acquires Two Companies—Rise Bar & OolaNovember 14, 2022 | finance.yahoo.comUSANA Named Top Manufacturer in UtahSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address USNA Company Calendar Last Earnings2/07/2023Today3/27/2023Next Earnings (Estimated)4/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Medicinals & botanicals Sub-IndustryPersonal Products SectorMedical Current SymbolNYSE:USNA CUSIP90328M10 CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,900Year FoundedN/APrice Target and Rating Average Stock Price Forecast$52.75 High Stock Price Forecast$53.00 Low Stock Price Forecast$52.50 Forecasted Upside/Downside-14.0%Consensus RatingHold Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$3.59 Trailing P/E Ratio17.09 Forward P/E Ratio21.53 P/E GrowthN/ANet Income$69.35 million Net Margins6.94% Pretax Margin10.88% Return on Equity16.92% Return on Assets12.15% Debt Debt-to-Equity RatioN/A Current Ratio2.67 Quick Ratio2.21 Sales & Book Value Annual Sales$998.60 million Price / Sales1.19 Cash Flow$4.79 per share Price / Cash Flow12.81 Book Value$22.62 per share Price / Book2.71Miscellaneous Outstanding Shares19,290,000Free Float19,225,000Market Cap$1.18 billion OptionableOptionable Beta0.74 Key ExecutivesKevin G. GuestChairman & Chief Executive OfficerJim BrownPresidentWalter NootChief Operating OfficerG. Douglas HekkingChief Financial OfficerRobert Andrew SinnottChief Scientific OfficerKey CompetitorsCanopy GrowthNASDAQ:CGCCronos GroupNASDAQ:CRONbioteNASDAQ:BTMDArcus BiosciencesNYSE:RCUSDefinitive HealthcareNASDAQ:DHView All CompetitorsInsiders & InstitutionsKevin GuestSold 5,297 sharesTotal: $318,614.55 ($60.15/share)Kevin GuestSold 13,288 sharesTotal: $801,000.64 ($60.28/share)DGS Capital Management LLCBought 4,545 shares on 2/21/2023Ownership: 0.024%Joshua FoukasSold 3,771 sharesTotal: $230,068.71 ($61.01/share)Gilbert A. FullerSold 404 sharesTotal: $24,987.40 ($61.85/share)View All Insider TransactionsView All Institutional Transactions USNA Stock - Frequently Asked Questions Should I buy or sell USANA Health Sciences stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" USNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in USNA, but not buy additional shares or sell existing shares. View USNA analyst ratings or view top-rated stocks. What is USANA Health Sciences' stock price forecast for 2023? 2 analysts have issued 1-year price objectives for USANA Health Sciences' shares. Their USNA share price forecasts range from $52.50 to $53.00. On average, they expect the company's share price to reach $52.75 in the next twelve months. This suggests that the stock has a possible downside of 14.0%. View analysts price targets for USNA or view top-rated stocks among Wall Street analysts. How have USNA shares performed in 2023? USANA Health Sciences' stock was trading at $53.20 at the beginning of the year. Since then, USNA shares have increased by 15.3% and is now trading at $61.36. View the best growth stocks for 2023 here. When is USANA Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 25th 2023. View our USNA earnings forecast. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) issued its earnings results on Tuesday, February, 7th. The company reported $0.66 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.31. The company had revenue of $227.96 million for the quarter. USANA Health Sciences had a trailing twelve-month return on equity of 16.92% and a net margin of 6.94%. During the same quarter in the prior year, the business posted $1.03 EPS. What ETFs hold USANA Health Sciences' stock? ETFs with the largest weight of USANA Health Sciences (NYSE:USNA) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC), Roundhill Acquirers Deep Value ETF (DEEP), Global X Health & Wellness ETF (BFIT), ETC 6 Meridian Low Beta Equity Strategy ETF (SIXL), First Trust Active Factor Small Cap ETF (AFSM), Pacer US Small Cap Cash Cows 100 ETF (CALF), First Trust Small Cap Value AlphaDEX Fund (FYT) and Royce Quant Small-Cap Quality Value ETF (SQLV). What guidance has USANA Health Sciences issued on next quarter's earnings? USANA Health Sciences issued an update on its FY 2023 earnings guidance on Friday, February, 24th. The company provided EPS guidance of $2.35-$3.30 for the period, compared to the consensus earnings per share estimate of $3.35. The company issued revenue guidance of $850.00 million-$950.00 million, compared to the consensus revenue estimate of $959.85 million. What is Kevin Guest's approval rating as USANA Health Sciences' CEO? 68 employees have rated USANA Health Sciences Chief Executive Officer Kevin Guest on Glassdoor.com. Kevin Guest has an approval rating of 99% among the company's employees. This puts Kevin Guest in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other USANA Health Sciences investors own include International Business Machines (IBM), Gilead Sciences (GILD), NVIDIA (NVDA), AT&T (T), BioMarin Pharmaceutical (BMRN), Vertex Pharmaceuticals (VRTX), AbbVie (ABBV), Walt Disney (DIS), Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ). What is USANA Health Sciences' stock symbol? USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA." Who are USANA Health Sciences' major shareholders? USANA Health Sciences' stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (6.38%), Pzena Investment Management LLC (3.73%), Dimensional Fund Advisors LP (2.87%), Geode Capital Management LLC (1.18%), Charles Schwab Investment Management Inc. (0.99%) and Morgan Stanley (0.99%). Insiders that own company stock include Brent Neidig, Daniel A Macuga, Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Gilbert A Fuller, Jim Brown, John Turman Fleming, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott, Robert Auciaux, Timothy E Wood and Walter Noot. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is USANA Health Sciences' stock price today? One share of USNA stock can currently be purchased for approximately $61.36. How much money does USANA Health Sciences make? USANA Health Sciences (NYSE:USNA) has a market capitalization of $1.18 billion and generates $998.60 million in revenue each year. The company earns $69.35 million in net income (profit) each year or $3.59 on an earnings per share basis. How many employees does USANA Health Sciences have? The company employs 1,900 workers across the globe. How can I contact USANA Health Sciences? USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The official website for the company is www.usana.com. The company can be reached via phone at (801) 954-7100, via email at investor.relations@usanainc.com, or via fax at 801-954-7300. This page (NYSE:USNA) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.